Crossmark

Wirkstoff zur HAE-Prophylaxe in EU zugelassen

Crossref DOI link: https://doi.org/10.1007/s15012-026-9048-9

Published Online: 2026-03-23

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2026-03-01

Version of Record valid from 2026-03-01
More Information

Article History

First Online: 23 March 2026

Free to read: This content has been made available to all.